Nisoldipine

Overview

4.3 out of 5 (7 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

28 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Nisoldipine, a dihydropyridine calcium channel blocker, is a drug used for the management of hypertension. This medication exerts its therapeutic effects by inhibiting calcium influx and blocking voltage-gated calcium channels in systemic smooth muscle cells. By reducing calcium levels, nisoldipine dilates coronary and systemic arteries. According to the American College of Cardiology/American Heart Association guidelines, nisoldipine is recommended as a first-line therapy for hypertension. It can be used as a standalone treatment or with other antihypertensive agents, such as angiotensin-converting enzyme inhibitors, diuretics, or beta-blockers. Additionally, this drug exhibits potential off-label applications for addressing ischemic heart conditions, including stable angina and Prinzmetal angina. This activity explores nisoldipine's indications, contraindications, adverse effects, and essential factors such as dosing, pharmacodynamics, pharmacokinetics, monitoring, and pertinent interactions.


UAN: JA4008338-0000-23-149-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify patients who may benefit from nisoldipine therapy based on their medical history, blood pressure readings, and cardiovascular risk factors.

  • Differentiate nisoldipine from other calcium-channel blockers by understanding its specific pharmacokinetic and pharmacodynamic properties.

  • Implement appropriate dosing regimens and treatment plans for patients receiving nisoldipine, considering individualized factors such as age, comorbidities, and concurrent medications.

  • Develop collaboration with other healthcare professionals to ensure coordinated care and comprehensive management of patients receiving nisoldipine.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-149-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Casey G. on 7/6/2021

Mary C. on 11/14/2021

Carl W. on 8/17/2022

susan m. on 11/15/2022

Brooke R. on 1/3/2024

Kathleen on 9/3/2023

Stephanie C. on 5/25/2021

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user